Table 5.
Relationship of CDK5 expression with other clinicopathological variables in adenosquamous carcinoma
| Characteristic | Total number | No. patients, stratified by CDK5 | Z | P value | |
|---|---|---|---|---|---|
| Negative (14) | Positive (20) | ||||
| Age | −0.122 | 0.918a | |||
| ≤44 | 19 | 8 (42.1 %) | 11 (57.9 %) | ||
| >44 | 15 | 6 (40.0 %) | 9 (60.0 %) | ||
| Lymph node metastasis | −1.857 | 0.120a | |||
| Negative | 26 | 13 (50.0 %) | 13 (50.0 %) | ||
| Positive | 8 | 1 (12.5 %) | 7 (87.5 %) | ||
| FIGO stage | |||||
| I–II | 26 | 13 (50.0 %) | 13 (50.0 %) | −1.857 | 0.120a |
| III–IV | 8 | 1 (12.5 %) | 7 (87.5 %) | ||
| TNM stage | |||||
| I | 24 | 13 (54.2 %) | 11 (45.8 %) | 5.518 | 0.019a |
| II–IV | 10 | 1 (10.0 %) | 9 (90.0 %) | ||
ND no data, FIGO International Federation of Gynecology and Obstetrics, TNM tumor node metastasis
aTwo independent-samples Chi-square test was performed